BRG
QDEL icon

Bay Rivers Group’s QuidelOrtho QDEL Stock Holding History

Bay Rivers Group’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,519
Closed -$273K – 75
2020
Q4 		$273K Buy
1,519
+245
+19% +$54.5K 0.23% 64
2020
Q3 		$279K Buy
+1,274
New +$284K 0.26% 58

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bay Rivers Group's QDEL Position: Q1 2021 in Review

Bay Rivers Group sold out of QuidelOrtho (QDEL) in Q1 2021, closing a stake of 1,519 shares — an estimated $273K sold.

Bay Rivers Group first reported a position in QDEL in Q3 2020 and held it in 2 quarters. The position peaked at $279K in Q3 2020. 349 funds tracked by Wall St. Rank hold QDEL as of Q1 2021.

  • Bay Rivers Group reported no remaining QuidelOrtho position as of Q1 2021 after selling out during the quarter.
  • Bay Rivers Group sold 1,519 QuidelOrtho shares in Q1 2021, an estimated $273K.
  • Bay Rivers Group first reported a position in QuidelOrtho in Q3 2020 and held it in 2 quarters.
  • Bay Rivers Group's QuidelOrtho position peaked at $279K in Q3 2020.
  • 349 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2021.

Based on Bay Rivers Group's 13F filing for Q1 2021, filed 14 Apr 2021.